Skip to content

Evaluation of web-based cognitive and behavioural therapeutic components and its change mechanisms for Arab people with posttraumatic stress disorder

Evaluation of web-based cognitive and behavioural therapeutic components and its change mechanisms for Arab people with posttraumatic stress disorder

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
DRKS
Registry ID
DRKS00010245
Enrollment
225
Registered
2016-03-30
Start date
2021-02-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F43.1

Interventions

Group 1: Web-delivered exposure-focused therapy: The exposure-based intervention is based on a Dutch web-based cognitive behavioural treatment approach for PTSD (Interapy) that is translated into mode

Sponsors

Zentrum Überleben gGmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: a) Arabic speaking (speak, read and write Arabic fluently) b) Internet access during the treatment period c) a personal E-mail account d) history of trauma and posttraumatic stress symptoms according to DSM-5

Exclusion criteria

Exclusion criteria: a) substance abuse or dependency b) psychotic symptoms c) acute suicidal tendency d) current psychotherapeutic treatment e) changes in psychotropic medication in the last four weeks f) ongoing traumatization g) high depression h) bipolar disorder i) Participation in the online-based intervention less than 6 months ago

Design outcomes

Primary

MeasureTime frame
Posttraumatic stress symptoms will be assessed by the PTSD Checklist for DSM-5 (PCL-5; Weathers, Litz, et al., 2013) at T0, T1, T2 and T3. Additionally, posttraumatic stress symptoms will be evaluated during treatment. T0 = pre-treatment T1 = post-treatment T2 = 3 months after end of treatment T3 = 6 months after end of treatment

Secondary

MeasureTime frame
Psychopathological secondary outcome measures: Depression will be assessed by the Patient Health Questionnaire- Depression Module (PHQ-9; Kroenke, Spitzer, & Williams, 2001) at T0, T1, T2 and T3. Anxiety will be assessed by the Generalized Anxiety Disorder Scale-7 (GAD-7; Spitzer, Kroenke, Williams, & Löwe, 2006) at T0, T1, T2 and T3. Somatic symptoms will be assessed by Patient Health Questionnaire- Somatisation Module (PHQ-15; Kroenke, Spitzer, & Williams, 2002) at T0, T1, T2 and T3. Quality of life will be assessed by the EUROHIS - Quality of Life (Schmidt, Mühlan, & Power, 2006) at T0, T1, T2 and T3. Trauma-related secondary outcome measures: Posttraumatic negative beliefs will be assessed with the Posttraumatic Maladaptive Beliefs Scale (PMBS; Vogt et al., 2012) at T0, T1, T2 and T3. Guilt cognitions will be assessed with items from the Trauma-Related Guilt Inventory (TRGI; Kubany et al., 1996) at T0, T1,T2 and T3. Posttraumatic emotions and cognitions will be assessed by the Trauma Appraisal Questionnaire (TAQ; DePrince et al., 2010) at T0, T1, T2 and T3. Complicated grief will be assessed by the Prolonged Grief Disorder 13 (PG-13; Prigerson & Maciejewski, 2007). Patients evaluation of treatment (satisfaction, working alliance, side effects): Acceptance of and satisfaction with the online- based treatment will be assessed by self-generated questions (e.g., would you recommend the treatment to another person?) and the Working Alliance Inventory - Short Form (Munder et al., 2010) at T1. Negative effects of the interventions will be assessed by the inventory for the assessment of negative effects of psychotherapy (INEP; Ladwig et al., 2014) at T1, T2 and T3. Additional measures (e.g. for subgroup analysis): Social Support will be assessed by the Multidimensional Scale of Perceived Social Support (MSPSS; Zimet et al., 1988). T0 = pre-treatment T1 = post-treatment T2 = 3 months after end of treatment T3 = 6 months after end of trea

Countries

Algeria, Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libya, Mauritania, Morocco, Oman, Palestinian Territories, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, United Arab Emirates, Western Sahara, Yemen

Contacts

Public ContactSophie Clever

Zentrum Überleben gGmbH

s.clever@ueberleben.org+49 (0)30 30390671

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026